论文部分内容阅读
目的:观察复方野西瓜通痹酊经皮离子导入治疗类风湿关节炎的临床疗效。方法:将117例类风湿关节炎患者采用随机数字表法随机分为治疗组60例和对照组57例,治疗组给予复方野西瓜通痹酊经皮离子导入治疗,对照组给予云南白药气雾剂治疗。两组均以6 d为1个疗程,共治疗2个疗程。结果:治疗组完全缓解0例,ACR 70 27例,ACR 5031例,ACR 20 2例,有效率占96.7%;对照组完全缓解0例,ACR 70 19例,ACR 50 28例,ACR 20 10例,有效率占82.5%。两组疗效对比,差别有统计学意义(P<0.05)。结论:复方野西瓜通痹酊经皮离子导入治疗类风湿关节炎疗效确切。
Objective: To observe the clinical efficacy of compound wild watermelon tongbi tincture percutaneous iontophoresis in the treatment of rheumatoid arthritis. Methods: A total of 117 patients with rheumatoid arthritis were randomly divided into treatment group (n = 60) and control group (n = 57). The treatment group was treated with percutaneous iontophoresis of compound wild watermelon tongbi tincture, while the control group was treated with Baiyijing aerosol Agent treatment. Both groups were 6 days for a course of treatment, a total of 2 courses of treatment. Results: In the treatment group, 0 cases were completely relieved, ACR 70 27 cases, ACR 5031 cases and ACR 20 2 cases, the effective rate was 96.7%. In the control group 0 cases were completely relieved, 19 ACR 70 cases, ACR 50 50 cases and ACR 20 10 cases , Efficiency accounted for 82.5%. The two groups were compared, the difference was statistically significant (P <0.05). Conclusion: The compound wild watermelon Tongbi tincture percutaneous iontophoresis treatment of rheumatoid arthritis curative effect is exact.